Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.[1]

References

  1. ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-24.


Allikas: https://en.wikipedia.org/wiki/Nerelimomab
No tags for this post.